Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-08 Kim Jong Joseph Chief Executive Officer Shares withheld for taxes −10,755 $6.29 $68K 2,103,875
2017-05-08 Kim Jong Joseph Chief Executive Officer Exercise or conversion · Restricted Stock Unit −23,333 23,333
2017-03-31 Kim Jong Joseph Chief Executive Officer Exercise or conversion +73,590 $5.08 $374K 2,164,887
2017-03-31 Kim Jong Joseph Chief Executive Officer Sale −73,590 $6.57 $484K 2,091,297
2017-03-31 Kim Jong Joseph Chief Executive Officer Exercise or conversion · Common Stock Option −73,590 0
2017-03-30 Kim Jong Joseph Chief Executive Officer Exercise or conversion +73,590 $5.08 $374K 2,164,887
2017-03-30 Kim Jong Joseph Chief Executive Officer Sale −73,590 $6.51 $479K 2,091,297
2017-03-30 Kim Jong Joseph Chief Executive Officer Exercise or conversion · Common Stock Option −73,590 73,590
2017-03-27 COLLINS MORTON Director Purchase +21,300 $6.25 $133K 50,000
2017-03-21 Bickerstaff George Director Grant or award · Common Stock Option +20,000 $5.86 $117K 20,000
2017-03-21 Bickerstaff George Director Grant or award · Restricted Stock Unit +12,270 12,270
2017-03-10 Sardesai Niranjan Chief Operating Officer Exercise or conversion +6,077 86,942
2017-03-10 Sardesai Niranjan Chief Operating Officer Shares withheld for taxes −1,859 $6.68 $12K 85,083
2017-03-10 Sardesai Niranjan Chief Operating Officer Grant or award · Common Stock Option +100,000 $6.68 $668K 100,000
2017-03-10 Sardesai Niranjan Chief Operating Officer Grant or award · Restricted Stock Unit +61,300 61,300
2017-03-10 Bagarazzi Mark Chief Medical Officer Grant or award · Common Stock Options +100,000 $6.68 $668K 100,000
2017-03-10 Bagarazzi Mark Chief Medical Officer Grant or award · Restricted Stock Unit +61,300 61,300
2017-03-10 Kim Jong Joseph Chief Executive Officer Exercise or conversion +139,745 2,143,902
2017-03-10 Kim Jong Joseph Chief Executive Officer Shares withheld for taxes −52,605 $6.68 $351K 2,091,297
2017-03-10 Kim Jong Joseph Chief Executive Officer Grant or award · Common Stock Option +43,150 $6.68 $288K 43,150

Page 45 of 49 · 961 trades